Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities

dc.contributor.authorOben, Bénedith
dc.contributor.authorFroyen, Guy
dc.contributor.authorMaclachlan, Kylee H.
dc.contributor.authorLeongamornlert, Daniel
dc.contributor.authorAbascal, Federico
dc.contributor.authorZheng-Lin, Binbin
dc.contributor.authorYellapantula, Venkata
dc.contributor.authorDerkach, Andriy
dc.contributor.authorGeerdens, Ellen
dc.contributor.authorDiamond, Benjamin T.
dc.contributor.authorArijs, Ingrid
dc.contributor.authorMaes, Brigitte
dc.contributor.authorVanhees, Kimberly
dc.contributor.authorHultcrantz, Malin
dc.contributor.authorManasanch, Elisabet E.
dc.contributor.authorKazandjian, Dickran
dc.contributor.authorLesokhin, Alexander
dc.contributor.authorDogan, Ahmet
dc.contributor.authorZhang, Yanming
dc.contributor.authorMikulasova, Aneta
dc.contributor.authorWalker, Brian
dc.contributor.authorMorgan, Gareth
dc.contributor.authorCampbell, Peter J.
dc.contributor.authorLandgren, Ola
dc.contributor.authorRummens, Jean-Luc
dc.contributor.authorBolli, Niccolò
dc.contributor.authorMaura, Francesco
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2024-07-17T11:48:51Z
dc.date.available2024-07-17T11:48:51Z
dc.date.issued2021-03-25
dc.description.abstractMultiple myeloma (MM) is consistently preceded by precursor conditions recognized clinically as monoclonal gammopathy of undetermined significance (MGUS) or smoldering myeloma (SMM). We interrogate the whole genome sequence (WGS) profile of 18 MGUS and compare them with those from 14 SMMs and 80 MMs. We show that cases with a non-progressing, clinically stable myeloma precursor condition (n = 15) are characterized by later initiation in the patient’s life and by the absence of myeloma defining genomic events including: chromothripsis, templated insertions, mutations in driver genes, aneuploidy, and canonical APOBEC mutational activity. This data provides evidence that WGS can be used to recognize two biologically and clinically distinct myeloma precursor entities that are either progressive or stable.
dc.eprint.versionFinal published version
dc.identifier.citationOben B, Froyen G, Maclachlan KH, et al. Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities. Nat Commun. 2021;12(1):1861. Published 2021 Mar 25. doi:10.1038/s41467-021-22140-0
dc.identifier.urihttps://hdl.handle.net/1805/42279
dc.language.isoen_US
dc.publisherSpringer Nature
dc.relation.isversionof10.1038/s41467-021-22140-0
dc.relation.journalNature Communications
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourcePMC
dc.subjectCancer genomics
dc.subjectMyeloma
dc.subjectPredictive markers
dc.titleWhole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Oben2021Whole-CCBY.pdf
Size:
5.11 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: